|
C2ORF47 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.16649997941687E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.02060000006787E-07 |
| Normal-vs-Stage2 |
1.750760E-04 |
| Normal-vs-Stage3 |
8.823900E-04 |
| Normal-vs-Stage4 |
8.175200E-04 |
| Stage1-vs-Stage2 |
7.037400E-01 |
| Stage1-vs-Stage3 |
2.158000E-01 |
| Stage1-vs-Stage4 |
9.248200E-01 |
| Stage2-vs-Stage3 |
5.266000E-01 |
| Stage2-vs-Stage4 |
8.452800E-01 |
| Stage3-vs-Stage4 |
4.783800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.40689998224298E-09 |
| Normal-vs-AfricanAmerican |
6.80520000351237E-08 |
| Normal-vs-Asian |
4.768000E-01 |
| Caucasian-vs-AfricanAmerican |
9.318600E-01 |
| Caucasian-vs-Asian |
4.587800E-01 |
| AfricanAmerican-vs-Asian |
4.532200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.05160002927818E-09 |
| Normal-vs-Female |
2.81909999999552E-06 |
| Male-vs-Female |
1.658050E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.21269999995033E-07 |
| Normal-vs-Extreme_Weight |
4.93050045236032E-10 |
| Normal-vs-Obese |
1.21410000053501E-07 |
| Normal-vs-Extreme_Obese |
1.305800E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.686600E-01 |
| Normal_Weight-vs-Obese |
8.970800E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.486000E-01 |
| Extreme_Weight-vs-Obese |
4.313200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.719400E-01 |
| Obese-vs-Extreme_Obese |
2.501200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.312400E-02 |
| Normal-vs-Age(41-60Yrs) |
2.53709997455331E-09 |
| Normal-vs-Age(61-80Yrs) |
1.52189999491625E-08 |
| Normal-vs-Age(81-100Yrs) |
1.401570E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.808410E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.834000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.385600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.826200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.097200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.327000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.66779931479277E-11 |
| Normal-VS-Type2 PRCC |
1.937240E-03 |
| Normal-VS-KIRP CIMP |
1.157630E-02 |
| Normal-VS-Unclassified PRCC |
2.01290000001464E-07 |
| Type1 PRCC-VS-Type2 PRCC |
2.383400E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.694220E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.690800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.264200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.889600E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.813400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.50611999999439E-05 |
| Normal-vs-N1 |
5.680100E-03 |
| Normal-vs-N2 |
7.817300E-03 |
| N0-vs-N1 |
1.452440E-01 |
| N0-vs-N2 |
6.391800E-01 |
| N1-vs-N2 |
2.207600E-01 |
|
|
